STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy

Launched by UNIVERSITY OF PITTSBURGH · Aug 21, 2020

Keywords

ClinConnect Summary

The prevalence of opioid use disorder (OUD) during pregnancy has quadrupled over the past decade, as have maternal and neonatal morbidity and mortality related to substance use. Medication assisted treatment (MAT) use during pregnancy reduces adverse outcomes and is the recommended, evidence-based practice (EBP) for OUD treatment during pregnancy. Despite this, 40% of pregnant women with OUD do not receive MAT. Currently, there are no effective strategies to expand MAT access and availability for pregnant women, especially in rural, low-resource settings where maternal opioid use is disprop...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Providers:
• • 1. provides prenatal care (i.e. obstetricians, nurse midwives, advanced practice providers) at obstetric sites,
• • 2. provides care to pregnant women with OUD
• • 3. English speaking
• Patient:
• • Maternal and child outcome data will be collected from the Electronic Health Record (EHR) and individual patients will not be recruited to participate in the randomized controlled trial (RCT).
• Inclusion criteria for a small subset of pregnant women will be recruited for a one-time qualitative interview (n=50):
• • 1. meet The Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for OUD
• • 2. received care at participating sites while pregnant during the study time period and
• • 3. speak English
• Exclusion Criteria:
• • None